Multinational study of the efficacy and safety of humanized anti HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease. - Cobleigh,M.A.; Vogel,C.L.; Tripathy,D.; Robert,N.J.; Scholl,S.; Fehrenbacher,L.; Wolter,J.M.; Paton,V.; Shak,S.; Lieberman,G.; Slamon,D.J. (J Clin Oncol, 1999)